Cited by 169Diabetes Management and ResearchTelemedicine and Telehealth ImplementationDiabetes Management and Education

Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control

Open access
Montori, Victor M., Helgemoe, Pamela K., Guyatt, Gordon H., Dean, Diana S., Leung, Teresa W., Smith, Steven A., Kudva, Yogish C.·2004·Diabetes Care

Abstract

OBJECTIVE—To determine the efficacy of telecare (modem transmission of glucometer data and clinician feedback) to support intensive insulin therapy in patients with type 1 diabetes and inadequate glycemic control. RESEARCH DESIGN AND METHODS—Thirty-one patients with type 1 diabetes on intensive insulin therapy and with HbA1c >7.8% were randomized to telecare (glucometer transmission with feedback) or control (glucometer transmission without feedback) for 6 months. The primary end point was 6-month HbA1c. To place our findings in context, we pooled HbA1c change from baseline reported in randomized trials of telecare identified in a systematic review of the literature. RESULTS—Compared with the control group, telecare patients had a significantly lower 6-month HbA1c (8.2 vs. 7.8%, P = 0.03, after accounting for HbA1c at baseline) and a nonsignificant fourfold greater chance of achieving 6-month HbA1c ≤7% (29 vs. 7%; risk difference 21.9%, 95% CI −4.7 to 50.5). Nurses spent 50 more min/patient giving feedback on the phone with telecare patients than with control patients. Meta-analysis of seven randomized trials of adult patients with type 1 diabetes found a 0.4% difference (95% CI 0–0.8) in HbA1c mean change from baseline between the telecare and control groups. CONCLUSIONS—Telecare is associated with small effects on glycemic control in patients with type 1 diabetes on intensive insulin therapy but with inadequate glycemic control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.27.5.1088

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R: Monitoring blood glucose control in diabetes mellitus: a sys- tematic review. Health Technol Assess 4:I- IV, 1-93, 2000
  2. Friedman L, Furberg C, DeMets D, Eds. New York, Springer, 1998, p. 69 -72
  3. Chase HP, Pearson JA, Wightman C, Rob- erts MD, Oderberg AD, Garg SK: Modem transmission of glucose values reduces the costs and need for clinic visits. Diabe- tes Care 26:1475-1479, 2003

Cited by

Sorted by citations

Authors
Montori, V. M., Helgemoe, P. K., Guyatt, G. H., Dean, D. S., Leung, T. W., Smith, S. A., & Kudva, Y. C.
Affiliations
  • Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, Minnesota
  • Mayo Clinic (US)
  • McMaster University (CA)
Venue
Diabetes Care
Published
2004-05-01
Volume
27
Issue
5
Pages
1088-1094
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2085134595
Cited by
169
References
1
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 9 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 9 · 2014: 7 · 2013: 16 · 2012: 13
FWCI
7.03
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
Mayo Foundation for Medical Education and Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
telecare, type 1 diabetes, glycemic control, intensive insulin therapy, HbA1c, clinician feedback, telemedicine
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Male, Middle Aged, Blood Glucose Self-Monitoring, Telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review